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Universite´ de Montre´al, Montre´al, CanadaABSTRACT Bioluminescence resonance energy transfer (BRET) is increasingly being used to monitor protein-protein inter-
actions and cellular events in cells. However, the ability to monitor multiple events simultaneously is limited by the spectral prop-
erties of the existing BRET partners. Taking advantage of newly developed Renilla luciferases and blue-shifted fluorescent
proteins (FPs), we explored the possibility of creating novel BRET configurations using a single luciferase substrate and distinct
FPs. Three new (to our knowledge) BRET assays leading to distinct color bioluminescence emission were generated and
validated. The spectral properties of two of the FPs used (enhanced blue (EB) FP2 and mAmetrine) and the selection of appro-
priate detection filters permitted the concomitant detection of two independent BRET signals, without cross-interference, in the
same cells after addition of a unique substrate for Renilla luciferase-II, coelentrazine-400a. Using individual BRET-based
biosensors to monitor the interaction between G-protein-coupled receptors and G-protein subunits or activation of different
G-proteins along with the production of a second messenger, we established the proof of principle that two new BRET config-
urations can be multiplexed to simultaneously monitor two dependent or independent cellular events. The development of this
new multiplexed BRET configuration opens the way for concomitant monitoring of various independent biological processes in
living cells.INTRODUCTIONBioluminescence resonance energy transfer (BRET) is
a natural phenomenon that occurs in a variety of coelenter-
ates, including Aequorea, Obelia, Phialidium, and Renilla.
It is based on the transfer of nonradiative energy originating
from the luciferase-mediated oxidation of coelenterazine
(the donor) to a fluorescent protein (FP) acting as the energy
acceptor, which reemits part of the energy as photons (1).
BRET occurs only when the donor and acceptor proteins
are in close proximity (typically <100 A˚) (2), and when
the emission spectrum of the donor overlaps sufficiently
with the excitation spectrum of the acceptor. The BRET
phenomenon can be easily detected if the Stoke’s shift
between the excitation and emission spectra of the FP is
sufficient for the light emission of the acceptor to be
spectrally resolved from the donor’s emission. Based on
these properties, and the fact that the efficacy of the transfer
varies with the 6th power of the distance between the
donor and the acceptor, previous studies used BRET as an
alternative to fluorescence resonance energy transfer
(FRET) as a proximity-based assay to monitor macromolec-
ular interactions and conformational rearrangements (3,4).
More precisely, the luciferase from Renilla reniformis
(Rluc) and different FP variants of Aequorea vitoria GFP
were genetically fused to distinct proteins to monitor their
possible interactions in living cells (5,6). In other cases,
the energy donor and acceptor were fused to a single protein
to monitor conformational changes that can be used as
biosensors of specific cellular events (7,8). More recently,Submitted June 28, 2010, and accepted for publication October 15, 2010.
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combined with Rluc-fused protein to monitor protein-lipid
(9) and protein-RNA interactions (10) in living mammalian
cells.
To date, three major BRET configurations using distinct
Rluc substrates and FPs have been developed and used for
protein-protein interaction and conformational rearrange-
ment monitoring. BRET1 uses coelenterazine-h (coel-h)
and a yellow FP (YFP) (5,6) or a green FP (GFP) from
Renilla (RGFP) (11), BRET2 utilizes coelenterazine-400a
(coel-400a) and a UV-excited green FP (uvGFP) (12,13),
and BRET3 makes use of coel-h and the monomeric orange
FP (mOrange) (14). Each of these BRET assays provides
advantages that can be exploited for specific applications.
BRET3, which results in the emission of red light, is less
likely to be quenched by biological tissues (compared to
yellow and green for BRET1 and BRET2, respectively) and
thus facilitates in vivo detection. BRET2 has the best signal/
noise ratio of the three configurations due to the larger Stoke’s
shift of the uvGFPs, and thus allows detection of smaller
BRET changes. BRET1 results in the highest absolute signal,
in part due to the very high quantum yield of YFP, permitting
detection of BRET between proteins expressed at lower
levels. However, none of the BRET partners used to date
have allowed for simultaneous spectral resolution of signals,
which is a prerequisite for true multiplexing within the same
cells in a single well. The ability to multiplex BRET signals
would allow investigators to detect distinct biological
processes simultaneously in a unique cell population.
With the objective of developing BRET configurations
that can be multiplexed, we searched for FPs that can serve
as BRET acceptors for Rluc/coel-400a. The identificationdoi: 10.1016/j.bpj.2010.10.025
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more flexibility in the use of BRET under different experi-
mental conditions, and could allow the use of an existing
collection of proteins already in fusion with different FPs.
For this purpose, we took advantage of the recently devel-
oped mutant form of Rluc (Rluc2) that increases its biolumi-
nescence by a factor of 3–45 times, depending on the
coelenterazine used as substrate (15). Such an increase in
the amount of energy emitted by Rluc2 should theoretically
allow monitoring of energy transfer to FPs, which cannot
be readily detected using wild-type (WT) Rluc, due to their
less than optimal excitation spectrum overlap with the donor
emission spectrum. The FPs to be tested were selected on the
basis that they can all be excited by the same energy donor
(Rluc/coel-400a), and they have sufficiently different Stoke’s
shifts to allow spectral resolution of their emission spectra.
In this study we established the ability of three additional
FPs (enhanced blue (EB) FP2, super cyan fluorescent protein
(SCFP3A), and mAmetrine) to accept energy transfer from
Rluc2/coel-400a, generating three new BRET configura-
tions. The spectral properties of mAmetrine and EBFP2
allowed their multiplexing with Rluc2/coel-400a as an
energy donor, thus permitting simultaneous monitoring of
two independent biological phenomena in the same cells.MATERIALS AND METHODS
Plasmids
All fusion proteins in this study were subcloned in pcDNA3.1 vector
(Invitrogen, Carlsbad, CA). Plasmids encoding all of the different G-protein
subunits, prostanoid TPa receptor (TPaR), and dopamine D2 receptor
(D2R) used in this study were purchased from the Missouri University of
Science and Technology (www.cdna.org). The GFP10-Gg2 construct was
previously described (16). Constructs for EBFP2-Gg2, SCFP3A-Gg2, or
mAmetrine-Gg2 were derived from GFP10-Gg2 by excising the GFP10
coding sequence with NheI-BamHI and replacing it with a polymerase
chain reaction (PCR)-amplified coding sequence of EBFP2, SCFP3A,
and mAmetrine, respectively. The mAmetrine-Gg1 was constructed by
replacing Gg2 from mAmetrine-Gg2 with Gg1 using Acc65I-XbaI endonu-
clease. The EBFP2 (17) and mAmetrine1.1 (18) were obtained from AddG-
ene (Cambridge, MA), and sCFP3 was generously provided by Dr. Gadella
(19). The V2R-Rluc2 fusion was done using PCR fragments from V2R
cDNAs and a mutant form of Rluc (15) in which C124 and M185 were
replaced by alanine and valine residues, respectively. This mutant Rluc,
named Rluc2, demonstrates an enhanced energy output from improved
enzymatic properties (see Fig. S1 in the Supporting Material). The Gaq-
121Rluc2 and Gai1-91Rluc2 were constructing by PCR overlapping to
insert the Rluc2 at position 121 and 91 of Gaq and Gai1, respectively.
The BRET-cAMP biosensors were derived from previously published
GFP10-EPAC-Rluc2 fusion protein (20), in which GFP10 was replaced
by the appropriate FPs using NheI-BamHI restriction enzymes
(as described above for the GFP10-g2) to generate EBFP2-EPAC-Rluc2,
SCFP3A-EPAC-Rluc2, and mAmetrine-EPAC-Rluc2. Sequence integrity
for the different clones was confirmed by DNA sequencing.Cell culture and transfection
HEK293T cells were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum, 100 U/mL penicillin/strepto-Biophysical Journal 99(12) 4037–4046mycin, and 2 mM L-glutamine (Wisent, Saint-Jean-Baptiste, Canada),
and incubated at 37C in 5% CO2. Two days before experiments were
conducted, 40,000 cells were distributed in 96-well white culture plates
(PerkinElmer, Waltham, MA) treated with poly-ornithine (Sigma-Aldrich,
St. Louis, MO) and transfected with 250 ng of total DNA using polyethy-
lenimine 25 kD linear (PEI; Polysciences, Warrington, PA) as transfecting
agent (3:1 PEI/DNA ratio). Then 11–50 ng of each specified expression
vector were diluted in 150 mM NaCl and the total quantity of DNA was
completed at 250 ng with salmon sperm DNA (Invitrogen, Carlsbad, CA).Bioluminescence and fluorescence spectral
profiles
Cells transiently expressing the individual FP-EPAC-Rluc2 fusion protein
were seeded at 100,000 cells/well in a 96-well white Optiplate
(PerkinElmer). The fluorescence spectra were acquired every 2 nm at
430–600 nm after excitation at 400 nm using a FlexStationII microplate
reader (Molecular Devices, Sunnyvale, CA) and expressed as a fraction
of the maximal emission (normalized to one) for each FP. The biolumines-
cence spectra were acquired every 5 nm at 360–600 nm after 2 min of
exposure to 5 mM coel-400a (Biotium, Hayward, CA) using the FlexStatio-
nII microplate reader. The bioluminescence was expressed as a fraction of
the maximal emission of the energy donor (normalized to one).BRET measurements
Transfected cells were washed twice with phosphate-buffered saline (PBS)
directly in the 96-well culture plates and kept in 100 mL of PBS. BRET
was monitored 10 min after the addition of 5 mM coel-400a in a Mithras
LB 940 microplate reader (Berthold Technologies, BadWildbad, Germany)
equippedwith different donor/acceptor emission filter sets (filter set 1: donor
480 5 20 nm/acceptor 530 5 20 nm; filter set 2: donor 410 5 70 nm/
acceptor 515 5 20 nm; filter set 3: donor 410 5 70 nm/acceptor 480 5
20 nm; and filter set 4: donor 4105 70 nm/acceptor 550 longpass). BRET
signals were derived from the emission detected with the energy acceptor
filter divided by the emission detected using the energy donor filter. Finally,
the specific BRET signal was defined as the difference between the total
BRET signals and the one obtained with Rluc2 alone. For the biolumines-
cence emission spectra experiments presented in Fig. 1, an mCherry-
EPAC-Rluc2 construct, which is not competent for BRET,was used to define
background values to be subtracted from those obtained from the spectrumof
each FP. Identical background values were obtained using either the Rluc2
or the mCherry-EPAC-Rluc2 construct alone.Multiplexing BRET assay
Transfected cells were washed and coel-400a was added as described for
regular BRET measurement. To monitor two energy transfers, the lumines-
cence signal was collected in the presence of three distinct filters, succes-
sively: 410 5 70 nm (common donor; Rluc2/coel-400a), 480 5 20 nm
(EBFP2 acceptor), and 550 longpass (mAmetrine acceptor). The signal was
collected for 1 s for each of the filters, for a total of 3 s per well of data acqui-
sition. The signals from each BRETwere derived from the emission detected
with the appropriate energy acceptor filter divided by the emission detected
using the energy donor filter (BRET400-BFP ¼ 480 5 20 nm over 410 5
70 nm, and BRET400-mAmetrine ¼ 550 longpass over 4105 70 nm). Finally,
the specific BRET signal was defined as the difference between the total
BRET signals and the one obtained in cells transfected with Rluc2 alone.Statistical analysis
We assessed the statistical significance of the difference between conditions
by performing two-way analyses of variance (ANOVAs) followed by
FIGURE 1 Bioluminescence and fluorescence
emission spectra. Bioluminescence emission
spectra of cells overexpressing EBFP2-EPAC-
Rluc2 (A, blue line), SCFP3A-EPAC-Rluc2 (B,
cyan line), GFP10-EPAC-Rluc2 (C, green line),
and mAmetrine-EPAC-Rluc2 (D, dark yellow
line), and negative control mCherry-EPAC-Rluc2
(A–D, black dotted line) were measured after the
addition of coel-400a. (E) The bioluminescence
of the mCherry-EPAC-Rluc2 control (which was
not different from the emission from Rluc2 alone,
since mCherry is not an acceptor for the Rluc2/
coel-400a) was subtracted from the emission spec-
trum for each FP-EPAC-Rluc2 fusion proteins and
normalized as a ratio of the maximal emission for
each FP. (F) Fluorescence spectra obtained from
cells overexpressing each of the FP-EPAC-Rluc2
fusion proteins was measured after direct excita-
tion at 400 nm. The curves were generated using
the LOWESS fitting equation from the Prism 4.0
software.
Multiplexing BRET Assays 4039Bonferroni post-tests using Prism 4.0 software (GraphPad Software, La
Jolla, CA).RESULTS
Bioluminescence spectra
BRET2 is characterized by an energy transfer from the
Rluc-mediated oxidation of coel-400a to the UV-shifted
GFPs that can be excited at 400 nm and reemit light at
510 nm (e.g., GFP2 and GFP10) (4). The recently described
FPs (EBFP2 (17), SCFP3A (19), and mAmetrine (18)),
which have different emission wavelengths and Stoke’s
shifts but close excitation peaks in the dark-blue region of
the spectrum, could therefore represent potential BRET
partners for Rluc2/coel-400a to create novel BRET config-
urations emitting at different colors. However, the subop-
timal spectrum overlap and lower quantum yield of these
FPs compared to GFP2 and GFP10 make them less attrac-tive. The development of Rluc2, which yields luminescence
signals 50 times larger than those generated by the WT
Rluc (Fig. S1) upon coel-400a oxidation may make it
possible to detect significant BRET despite these apparent
limitations. To assess possible energy transfer between
Rluc2/coel-400a and these FPs, we measured biolumines-
cence spectra from cells expressing an unimolecular
BRET-based cAMP-biosensor of each color: EBFP2-
EPAC-Rluc2, SCFP3A-EPAC-Rluc2, mAmetrine-EPAC-
Rluc2, and GFP10-EPAC-Rluc2. As shown in Fig. 1, A–D,
the spectra are characteristic of energy transfer, since in addi-
tion to the peak corresponding to the emission of Rluc2,
a second component corresponding to the expected emission
of the respective FPs was observed. To determine whether
the second component of the curves (which in some cases
(e.g., EBFP2) is a relatively small shoulder) truly results
from fluorophore reemission, we subtracted the spectrum
for a BRET noncompetent mCherry-EPAC-Rluc2 constructBiophysical Journal 99(12) 4037–4046
4040 Breton et al.(equivalent to Rluc2 alone) from the recorded spectrum for
each FP. As shown in Fig. 1E, the resulting spectra are essen-
tially identical to those obtained after direct light excitation
of each FP (Fig. 1 F), confirming that the second component
of the curves originated from an energy transfer to an FP.
Since all constructs have essentially the same structure
and sequence, except for a few mutations within FPs that
lead to their specific spectral properties, the observed differ-
ences in emission intensity result from their distinct intrinsic
ability to be excited and reemit transferred energy from the
Rluc2/coel-400a. The differences are dictated by the extent
of overlap between the Rluc2/coel-400a emission spectrum
and the excitation spectrum of a given FP, as well as the
quantum yield of the individual fluorophores. Based on
the spectral overlap, the best partners for energy transfer
from Rluc2/Coel400a are (in decreasing order) GFP10, mA-
metrine, SCFP3A, and EBFP2. This is consistent with the
amplitude of their emission peak (area under the curve):
GFP10 (175.8)> SCFP3A (127.1)zmAmetrine (121.0)>
EBFP2 (40.8), which reflects both the donor emission/
acceptor excitation overlap and the fluorophore quantum
yield. The relatively small reemission observed for EBFP2
is to be expected, given its relatively low quantum yield
and a left-shifted excitation maximum peak (386 nm)
compared to the other FPs (21). The above data illustrate
that energy transfer can be monitored between Rluc2/coel-
400a and the four UV-shifted FPs tested, supporting the
possible development of three new BRET assays with
EBFP2, SCFP3A, and mAmetrine. To prevent confusion
among the different Rluc-based BRET configurations, we
propose a new nomenclature that first indicates the emission
peak of the donor, and then the name of the prototypical FP
(which usually reflects its emission color) used for the trans-
fer. According to this nomenclature, the three new BRET
assays would be called BRET400-BFP, BRET400-CFP, and
BRET400-mAmetrine, whereas the existing BRET1, BRET2,
and BRET3 would become BRET480-YFP, BRET400-GFP,
and BRET480-Orange, respectively.Multicolor BRET
Given the different spectral properties of the confirmed
BRET pairs, we then explored whether some filter sets could
optimally detect their signals. For this purpose, we tested four
donor/acceptor filter sets (set 1: 480/530; set 2: 410/515; set
3: 410/480; and set 4: 410/550) for monitoring bimolecular
BRET between the V2 vasopressin receptor fused to Rluc2
(V2R-Rluc2) and the g2 subunit of an heterotrimeric
G-protein fused to the different FPs (FP-Gg2), upon stimula-
tion of the receptorwith increasing concentration of arginine-
vasopressin (AVP). As shown in Fig. 2, A–D, both basal and
AVP-promoted BRET increases were detected between
FP-Gg2 and V2R-Rluc2 for several FP and filter combina-
tions. The basal BRET signal has been attributed to precou-
pling of the receptor with the G-protein, whereas theBiophysical Journal 99(12) 4037–4046agonist-promoted increase reflects a functional engagement
of the G-protein by the receptor (16,22,23). The BRET
signals generated by specific FPswere differentially detected
by distinct filter sets, but perfect correlations between basal
and agonist-promoted BRET increases were observed inde-
pendently of the filter set used (Fig. 2 E), indicating that
the characteristics of the different filters affect only the
intensity of the detected signal and not its dynamics. For
identical acceptor/donor expression ratios, the agonist-
promoted BRET increases (expressed as % of the basal
BRET) were the same for all BRET pairs considered
(Fig. S2), indicating that the different BRET configurations
yield comparable responses. Also, the detected EC50-values
for theAVP-stimulated increase inBRETbetweenV2R-Rluc
and each FP-Gg2 were very similar for all FP and filter
combinations used. The optimal filter sets for detecting
BRET signals were different for each FP: filter set 1 was
optimal for GFP10 and mAmetrine, whereas filter set 3 was
best for SCFP3A and EBFP2, thus defining the optimal
detection conditions for the four BRET assays. It is note-
worthy that even for EBFP2, which yielded the weakest
energy transfer (Fig. 1 A), the selection of a proper filter set
allowed for the detection of a robust and highly reproducible
signal.
Interestingly, some of the filter sets did not detect the
BRET signal generated by some FPs (Fig. 2 and Fig. S2).
For example, no BRET could be detected with the mAme-
trine-Gg2 in filter set 3 or with EBFP2-Gg2 in filter set 4.
Yet, good BRET signals were observed for mAmetrine-
Gg2 with filter set 4, set 1, and, to a lesser extent, set 2;
and for EBFP2-Gg2 with filter set 3 and, to a lesser extent,
set 2 (Fig. 2). The absence of detected BRET between V2R-
Rluc2 and Gg2 with certain FPs and some filter sets did not
result from a lack of interaction, but from the inadequacy of
these filters to resolve the emissions resulting from energy
transfer. The fact that BRET between Rluc2 and either mA-
metrine or EBFP2 can be detected by distinct filter sets (sets
4 and 3, respectively) without contaminating the other signal
raises the possibility that two independent transfers between
a common donor and two acceptors can be monitored simul-
taneously within the same cells.Multiplexing BRET
To experimentally determine whether simultaneous
measurements of BRET between Rluc2 and both EBFP2
and mAmetrine can be used to differentially follow two
events within the same cells, we combined two BRET-based
biosensors: 1), a unimolecular cAMP-biosensor (mAme-
trine-EPAC-Rluc2) that senses the cAMP level by moni-
toring the conformational change of EPAC upon cAMP
binding; and 2), a bimolecular biosensor (EBFP2-Gg2 and
V2R-Rluc2) that detects the physical engagement of
a G-protein subunit by V2R. Because Ga12 was previously
shown to potentiate receptor-mediated activation of
FIGURE 2 Multicolor BRET measurements. (A–D) BRET between V2R-Rluc2 and GFP10-Gg2 (green), EBFP2-Gg2 (blue), SCFP3A-Gg2 (cyan), or
mAmetrine-Gg2 (dark yellow) were measured in cells coexpressing the indicated BRET partners and Ga12, in the presence or absence of increasing concen-
trations of AVP. Cells were stimulated for 20 min with the indicated concentration of AVP, and coel-400a was added 10 min before the readings were
taken. BRET was measured using four different filter sets (see characteristics in the Materials and Methods section), as indicated in the panels. Results
are expressed as the means 5 SE of three independent experiments performed in triplicate. Curves were analyzed using a nonlinear regression sigmoid
fit from the Prism 4.0 software. The EC50 (nM) is indicated for each FP within each filter set. (E) The maximal AVP-promoted BRET for each pair is plotted
as a function of their basal BRET signals. The linear correlations for the four filter sets were obtained using a linear regression fit from the Prism 4.0 software
and are depicted by the four lines in the graph.
Multiplexing BRET Assays 4041adenylyl cyclase (24), we performed the assays in the pres-
ence of coexpressed Ga12 to increase the size of the signal
(Fig. S3). The two BRET events were monitored with three
filters (filter set 5) composed of the common donor filter
410 5 70 nm, and the optimal acceptor filters for mAme-
trine (set 4: 550 longpass) and EBFP2 (set 3: 480 5
20 nm) to follow the two energy transfers. In cells coex-
pressing V2R-Rluc2 and EBFP2-Gg2, a significant basal
increase and an AVP-promoted increase in BRET400-BFPwere detected (Fig. 3 A), reflecting the engagement of the
G-protein by the receptor, whereas no significant
BRET400-mAmetrine was observed (Fig. 3 B). In cells coex-
pressing V2R-Rluc2 and mAmetrine-EPAC-Rluc2, a signif-
icant AVP- and forskolin-promoted decrease in
BRET400-mAmetrine was detected (Fig. 3 B), indicating an
increase in cAMP levels, whereas no BRET400-BFP was de-
tected in these cells (Fig. 3 A). These results confirm the
selectivity of each filter set for detecting only one of theBiophysical Journal 99(12) 4037–4046
FIGURE 3 Multiplexing BRET. BRET400-BFP
(A) and BRET400-mAmetrine (B) were measured in
cells expressing the indicated combination of
V2R-Rluc2, EBFP2-Gg2, and mAmetrine-EPAC-
Rluc2. BRET was measured in the absence of
ligand (Ctl) or after 20 min stimulation with AVP
(100 nM) or forskolin (100 mM). Coel-400a
was added 10 min before readings were taken,
using a single energy donor filter (410 5 70 nm)
and two different energy acceptor filters
(480 5 20 nm for BRET400-BFP and 550LP for
BRET400-mAmetrine). Two-way ANOVAs followed
by Bonferroni post-tests were used to assess the
statistical significance of the differences (**p <
0.001) using Prism 4.0 software. (C) BRET400-BFP
between V2R-Rluc2 and EBFP2-Gg2 (squares)
and BRET400-mAmetrine for the cAMP biosensor
mAmetrine-EPAC-Rluc2 (circles) were measured
simultaneously in cells coexpressing these
constructs, after 20 min stimulation with
increasing concentration of AVP. The results are
expressed as the means5 SE of three independent
experiments performed in triplicate. The curves
were generated using the nonlinear regression
sigmoid fit from Prism 4.0 software.
4042 Breton et al.two BRET events. In cells coexpressing V2R-Rluc2,
EBFP2-Gg2, and mAmetrine-EPAC-Rluc2, AVP promoted
a significant increase in BRET400-BFP (Fig. 3 A), reflecting
the engagement of EBFP2-Gg2 by V2R-Rluc2, as well as
a concomitant decrease in BRET400-mAmetrine (Fig. 3 B),
resulting from an increase in cAMP levels. Forskolin-stim-
ulated cAMP production also promoted a reduction in
BRET400-mAmetrine (Fig. 3 B) but did not affect BRET400-BFP
(Fig. 3 A), which is consistent with the ability of forskolin
to stimulate adenylyl cyclase independently of the
receptor/G-protein interaction. It is worth mentioning that
the basal BRET400-BFP observed in cells coexpressing
V2R-Rluc2, EBFP2-Gg2, and mAmetrine-EPAC-Rluc2
was lower than in cells expressing only V2R-Rluc2 and
EBFP2-Gg2 (Fig. 3 A). This can easily be explained by the
fact that BRET is a ratio of EBFP2-emission over Rluc2-
emission, and the Rluc2 signal originated from both V2R-
Rluc2 and mAmetrine-EPAC-Rluc2 in the former cells. It
is therefore important when setting up such assay to ensure
that the expression levels of each Rluc2-fused constructs
are maintained in similar ranges. Interestingly, however,
the AVP-promoted BRET400-BFP increasewas very similar in
the two conditions (73 5 29% vs. 60 5 11% for cells
expressing both Rluc2 biosensors or only one, respectively),
indicating that the presence of the two Rluc2-based biosen-Biophysical Journal 99(12) 4037–4046sors did not influence their dynamic response. As shown in
Fig. 3 C, in cells coexpressing V2R-Rluc2, EBFP2-Gg2,
and mAmetrine-EPAC-Rluc2, AVP promoted an increase
in BRET400-BFP and a decrease in BRET400-mAmetrine with
similar EC50-values.These results show for the first time, to
our knowledge, that multiplexing of two separate biosensors
expressed in the same cell population can be monitored after
a single coelenterazine addition. It should be noted that
although the coexpression of Ga12 increased the cAMP
signal, its presence was not required for detection of the
EPAC biosensor signal (Fig. S3).
To determine whether BRET400-mAmetrine and
BRET400-BFP-based biosensors can be multiplexed to
monitor the activation of other signaling pathways, we
directly monitored the activation of Gai by D2R by moni-
toring the BRET changes between Gai1-91Rluc2 and mA-
metrine-Gg2 upon stimulation of the D2R with quimpirol,
and monitoring cAMP accumulation with BRET480-BFP
using EBFP2-EPAC-Rluc2 (Fig. 4 A). As expected, the
stimulation with quimpirole promoted a decrease in BRET
between Gai1 and Gg2, indicating activation of Gai (16),
as well as an increase in the EPAC intramolecular BRET,
reflecting a decrease in cAMP resulting from the action of
activated Gai on the adenylyl cyclase. The effects of agonist
stimulation were blocked by pretreatment with pertussis
FIGURE 4 Multiplexing Gai or Gaq activation with cAMP production. BRET from cells expressing (A) D2 dopamine receptor, Gai1-91Rluc2, mAme-
trine-Gg2, and EBFP2-EPAC-Rluc2; or (B) TPaR, Gaq-121Rluc2, mAmetrine-Gg1, and EBFP2-EPAC-Rluc2 was measured either in the absence of
ligand or after 20 min stimulation with quimpirol (quim, 100 nM, A), U46619 (100 nM, B), and/or forskolin (Fsk, 100 mM, A and B), as indicated. For
the negative control in A, PTX (100 ng/mL) was added 16 h before the experiment. Coel-400a was added 10 min before readings were taken, using a single
energy donor filter (4105 70 nm) and two different energy acceptor filters (4805 20 nm for BRET400-BFP and 550LP for BRET400-mAmetrine). Two-way
ANOVAs followed by Bonferroni post-tests were used to assess the statistical significance of the differences (*p < 0.01, **p < 0.001) using Prism 4.0
software.
Multiplexing BRET Assays 4043toxin (PTX), which inhibits Gai activity. Direct activation of
the adenylyl cyclase with forskolin had no effect on the
BRET between Gai1 and Gg2, whereas it promoted
a decrease in the intramolecular EPAC resulting from the
increased cAMP. As expected, the latter effect was
completely resistant to PTX treatment. We also assessed
the activation of Gq by monitoring BRET400-mAmetrine
between Gaq-121Rluc2 and mAmetrine-Gg1 upon activa-
tion of the TPaR with the selective agonist U46619. As
shown in Fig. 4 B, activation with the agonist promoted
a decrease in BRET between Gaq and Gg1, reflecting Gq
activation, whereas it did not affect the EPAC intramolecu-
lar BRET400-BFP, consistent with the notion that activation of
TPaR does not affect cAMP levels. In the same cells, direct
stimulation of adenylyl cyclase by forskolin promoted
a decrease in the EPAC BRET but did not affect the Gaq-
Gg1 BRET. Taken together, these results indicate thatBRET400-mAmetrine and BRET400-BFP can be multiplexed to
monitor many distinct signaling pathways, and the BRET
signals obtained with the individual biosensors are indepen-
dent of one another.DISCUSSION
In this study we report the development of what we believe
are three new BRET configurations that complement the
existing ones, and provide for the first time, to our know-
ledge, a toolbox for simultaneous multiplexing of spectrally
resolved BRET assays within the same cells.Multicolor BRET
To date, three configurations of genetically encoded BRET
assays, with Rluc used as the energy donor, have beenBiophysical Journal 99(12) 4037–4046
4044 Breton et al.described. BRET1 and BRET3 use coel-h as the Rluc
substrate for transferring energy to YFPs (eGFP, eYFP,
citrine, venus, YPeT, and RGFP) and RFPs (mOrange,
mTomato, and sdTomato), respectively. BRET2 uses coel-
400a and Rluc as an energy donor, and uvGFPs (GFP10,
GFP2, and Sapphire) as energy acceptors. In this study,
three new BRET configurations are presented. They all
use coel-400a as the Rluc substrate and acceptor FPs that
can be excited at a similar wavelength (~400 nm) but emit
at different colors as a result of distinct Stoke’s shifts.
Of the four BRET400 FPs used in our study, the original
BRET400-GFP is still the one with the largest BRET signals
due to its superior quantum yield and better overlap between
the Rluc emission and FP excitation spectra. The lower
transfer efficacy toward BFP, CFP, and mAmetrine as
compared to GFP10 most likely explains why BRET signals
obtained with these FPs have not been reported until now.
Only the availability of Rluc mutant forms, such as Rluc8
and Rluc2 (15,25), that emit higher levels of biolumines-
cence upon oxidation of coel-400a, raised the possibility
of using BFP, CFP, and mAmetrine as viable BRET400
acceptors. Indeed, in our hands, the amount of light emitted
by Rluc2 was 50-fold higher than that emitted by the WT
enzyme (Fig. S1), which led to detectable transfer to BFP,
CFP, and mAmetrine despite a suboptimal overlap between
Rluc2/coel-400a emission and FPs excitation spectra.
Furthermore, because of the higher bioluminescence of
Rluc2, one can achieve easily measurable BRET signals
with coel-400a using much lower expression levels than
previously needed for classical BRET2. For instance,
when a standard curve correlating the luminescence signal
to the density of V2R (assessed by radioligand binding)
was generated (data not shown), the levels of V2R needed
to obtain the BRET signals reported in Fig. 2 and Fig. S2
were estimated to be between 110 and 325 fmol/mg of
protein. Such expression levels are comparable to those
measured in kidney tissues and kidney cells (130 and 310
fmol/mg, respectively (26)).
The selection of optimal filter sets to quantify the BRET
generated by specific fluorophores is also an important
factor in obtaining the best signal/noise ratio. Larger
BRET ratios are obtained by selecting filters that favor the
detection of the FP over that of the Rluc emission. However,
it is important to select a filter band-pass that will allow the
detection of a sufficient amount of light to remain within the
linear dynamic range of the detectors and avoid affecting
the linearity of the signals. A good illustration of this
phenomenon is provided by the observation that the filter
sets that generate the largest signal for BRET400-GFP are
Rluc em: 480 5 20 nm and GFP em: 530 5 20, and not
Rluc em: 410 5 35 nm and GFP em: 515 5 15 nm
(compare Fig. 2, A and B), which are commonly use for
this type of BRET experiment (12,13). The filter sets used
do not affect the dynamics of the response, since the
increase in basal signal was found to be directly propor-Biophysical Journal 99(12) 4037–4046tional to the ligand-promoted increase in BRET observed
between V2-Rluc2 and GFP-Gg2 (Fig. 2 E). However, the
larger absolute signals obtained could allow the detection
of small BRET signals that might be lost in the background
noise when nonoptimal filter sets are used.
Although BRET400-GFP, which corresponds to traditional
BRET2, remains the BRET system that generates the largest
signal with Rluc2/coel-400a, access to additional BRET
colors provides several advantages. First, the ability to
perform BRET400-CFP provides an interesting alternative
because it allows the direct use of the many proteins and
protein libraries (generated to study proteins localization
or protein interactions by FRET) that are already CFP-
tagged. Moreover, some FPs, such as mAmetrine and
EBFP2, have similar excitation profiles but different Stoke’s
shifts, resulting in spectrally resolvable emission spectra
that allow multiplexing for the simultaneous detection of
two distinct BRET events with a single Rluc substrate in
living cells. It should also be noted that even though a single
prototypical FP was used for each of the new color
BRET configurations presented, a selection of FPs could
be used for two of them: BRET400-BFP (EBFP, EBFP2,
and mKalama1) and BRET400-CFP (ECFP, SCFP3A, CyPet,
mCerulean, and mTFP1.0). In some cases, the specific
biophysical properties of some FPs (e.g., pH sensitivity,
propensity to dimerize, and quantum yield) could make
them preferred choices.Multiplexing BRET
A few studies have described genetically encoded dual
FRET-based assays (27) that allow the detection of two
simultaneous FRET events within the same cells. These
assays provide the advantage of single-cell microscopy
imaging (27). However, the quantification of two FRET
events is complicated by the fact that only a limited numbers
of FP pairs are available for efficient transfer. For most
existing pairs, the excitation of the donor with a light source
leads to direct excitation of the acceptor. Moreover, the
emission spectra of the existing FP FRET acceptors are
similar, which makes it difficult to achieve spectral resolu-
tion and leads to spectral bleed-through. This necessitates
the use of mathematical correction factors, which are not
always easy to translate to practice and require additional
control measurements. BRET is more sensitive than FRET
for measuring RET with the use of plate readers. This is
due in part to the high sensitivity of the PMT detectors
used in plate readers, which allows easy detection of
BRET. Also, the autofluorescence originating from the light
excitation of the donor reduces the signal/noise ratio for
FRET (28). Thus, for different applications (i.e., imaging
versus activity detection in plate readers), either technique
may be preferred.
The results of this study demonstrate that two BRET
events can be monitored simultaneously within the same
Multiplexing BRET Assays 4045cells, thus permitting the simultaneous detection of distinct
biological outcomes. We have shown that BRET400-BFP and
BRET400-mAmetrine can be multiplexed to detect the confor-
mational rearrangement of a unimolecular cAMP biosensor
simultaneously with the engagement of G-proteins by their
cognate receptors. The activation of three distinct receptor/
G-protein signaling pathways can be easily monitored with
bimolecular sensors that monitor either the interaction
between the receptor and Gg or the receptor-mediated sepa-
ration between Ga and Gg. We observed BRET400-BFP and
BRET400-mAmetrine, triggered by the activation of the
receptor, within the same cells without cross-interference
from the individual signals. This multiplexing method is
distinct from and complementary to previously reported
BRET approaches. For instance, because of its ability to
monitor two events independently, the BRET400-BFP/
BRET400-mAmetrine multiplexing approach is different from
recently developed sequential RET (29) and bimolecular
fluorescence complementation BRET assays (30,31) that
were designed to monitor a single event involving three
partners. BRET400-BFP/BRET400-mAmetrine multiplexing,
which allows the monitoring of two BRET signals simulta-
neously in a single well, facilitates kinetic comparisons
between the two events and reduces the number of manipu-
lations needed, thus opening the door to high-throughput
screening applications.
In this study, we used BRET400-BFP/BRET400-mAmetrine
multiplexing to combine unimolecular biosensors (mAme-
trine-EPAC-Rluc2 or BFP-EPAC-Rluc2) with bimolecular
probes (V2R-Rluc2/EBFP2-Gg2, Gai1-91Rluc2/mAme-
trine-Gg2, or Gq-121Rluc2/mAmetrine-Gg1) for the detec-
tion of protein-protein interactions. However, the assays
would also allow one to combine two unimolecular biosen-
sors or three probes to monitor the interaction of one
partner in fusion with Rluc2 with two distinct partners in
fusion with mAmetrine and EBFP2. In the latter case, the
extent of BRET observed with each partner will be influ-
enced by the relative expression levels of the partners.
One can easily determine the optimal acceptor/donor
ratio to use for signal detection by performing BRET titra-
tion experiments for each FP individually, where the Rluc2-
fused construct is maintained constant and the level of the
FP-fused construct is increased (Fig. S2, B and C). Because
there is no spectral overlay between mAmetrine and EBFP2
when the appropriate filters are used, different ratios can
easily be used for the two multiplexed pairs without signal
contamination. Since the FPs used in the new BRET assays
did not influence the interaction or the modulation of the
interactions monitored, as shown by the similar amplitude
of the BRET change detected between V2R and Gg2 for
the different FP combinations used (Fig. 2 E), we expect
that the adaptation and optimization of known BRET inter-
actions into BRET multiplexing should be straightforward.
In addition to introducing three new (to our knowledge)
configurations of BRET, we have presented what we believeis a first proof of principle that spectrally resolved BRET
assays can be multiplexed to monitor two independent
cellular events. These assays will undoubtedly be valuable
tools for monitoring protein-protein interactions as well
as other events, such as second messenger production, for
which RET biosensors can be designed. The robustness
and easy implementation of these assays should ensure their
wide utilization and facilitate their combination with other
approaches, such as bimolecular fluorescence or lumines-
cence complementation assays (30,32), to increase the
number of interactions that can be simultaneously moni-
tored within the same cell.SUPPORTING MATERIAL
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